Skip to main content
Top
Published in: Acta Neuropathologica 6/2005

01-06-2005 | Regular Paper

PIK3CA mutations in glioblastoma multiforme

Authors: Christian Hartmann, Gesine Bartels, Claire Gehlhaar, Nikola Holtkamp, Andreas von Deimling

Published in: Acta Neuropathologica | Issue 6/2005

Login to get access

Abstract

Glioblastoma multiforme WHO grade IV is the most common and malignant variant of astrocytic tumors. Loss of heterozygosity of chromosome 10 and mutations in the tumor suppressor gene PTEN on 10q are molecular hallmarks of glioblastomas. Recently, mutations were identified in PIK3CA, encoding a protein that antagonizes the function of PTEN protein in the PI3K/Akt pathway. To address the question whether an exclusive mutation pattern can be observed in PIK3CA and PTEN, we determined the frequency of mutations in both genes. All coding exons were examined by single strand confirmation polymorphism and direct sequencing. Additionally, we analyzed chromosome 10 for loss of heterozygosity and evaluated the mutational status of TP53. In 70 glioblastomas, 5 (7%) PIK3CA mutations and 10 (14%) PTEN mutations were found. All mutations in PIK3CA located to exons 1, 9 and 20, thereby supporting the concept of mutational hot spot regions. In all but one glioblastoma, mutations were seen either in PIK3CA or in PTEN. In conclusion, the frequency of PIK3CA mutations in glioblastomas appears to be much lower than initially reported.
Literature
1.
go back to reference Broderick DK, Di C, Parrett TJ, et al (2004) Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64:5048–5050 Broderick DK, Di C, Parrett TJ, et al (2004) Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64:5048–5050
3.
go back to reference Duerr EM, Rollbrocker B, Hayashi Y, et al (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264CrossRefPubMed Duerr EM, Rollbrocker B, Hayashi Y, et al (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264CrossRefPubMed
4.
go back to reference Hartmann C, Numann A, Mueller W, et al (2004) Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Int J Cancer 108:839–844 Hartmann C, Numann A, Mueller W, et al (2004) Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Int J Cancer 108:839–844
5.
go back to reference Ichimura K, Bolin MB, Goike HM, et al (2000) Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 60:417–424PubMed Ichimura K, Bolin MB, Goike HM, et al (2000) Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 60:417–424PubMed
6.
go back to reference Kleihues P, Cavenee WK (2000) Pathology and genetics of tumours of the nervous system, 2nd edn. IARC Press, Lyon Kleihues P, Cavenee WK (2000) Pathology and genetics of tumours of the nervous system, 2nd edn. IARC Press, Lyon
7.
go back to reference Knobbe CB, Reifenberger G (2003) Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3’-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13:507–518PubMed Knobbe CB, Reifenberger G (2003) Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3’-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13:507–518PubMed
8.
go back to reference Louis DN, Deimling A von, Seizinger BR (1992) A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 141:777–782 Louis DN, Deimling A von, Seizinger BR (1992) A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 141:777–782
9.
go back to reference Ma YY, Wei SJ, Lin YC, et al (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19:2739–2744 Ma YY, Wei SJ, Lin YC, et al (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19:2739–2744
10.
go back to reference Miller CT, Moy JR, Lin L, et al (2003) Gene amplification in esophageal adenocarcinomas and Barrett’s with high-grade dysplasia. Clin Cancer Res 9:4819–4825 Miller CT, Moy JR, Lin L, et al (2003) Gene amplification in esophageal adenocarcinomas and Barrett’s with high-grade dysplasia. Clin Cancer Res 9:4819–4825
11.
go back to reference Racz A, Brass N, Heckel D, et al (1999) Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur J Cancer 35:641–646 Racz A, Brass N, Heckel D, et al (1999) Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur J Cancer 35:641–646
12.
go back to reference Rao RD, James CD (2004) Altered molecular pathways in gliomas: an overview of clinically relevant issues. Semin Oncol 31:595–604 Rao RD, James CD (2004) Altered molecular pathways in gliomas: an overview of clinically relevant issues. Semin Oncol 31:595–604
13.
go back to reference Reifenberger G, Collins VP (2004) Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656–670 Reifenberger G, Collins VP (2004) Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656–670
14.
go back to reference Samuels Y, Wang Z, Bardelli A, et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304:554 Samuels Y, Wang Z, Bardelli A, et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304:554
15.
go back to reference Tong CY, Hui AB, Yin XL, et al (2004) Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg Spine 100:187–193 Tong CY, Hui AB, Yin XL, et al (2004) Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg Spine 100:187–193
16.
go back to reference Woenckhaus J, Steger K, Werner E, et al (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198:335–342 Woenckhaus J, Steger K, Werner E, et al (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198:335–342
Metadata
Title
PIK3CA mutations in glioblastoma multiforme
Authors
Christian Hartmann
Gesine Bartels
Claire Gehlhaar
Nikola Holtkamp
Andreas von Deimling
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 6/2005
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-005-1000-1

Other articles of this Issue 6/2005

Acta Neuropathologica 6/2005 Go to the issue